Recently, we studied a series of infants who received propranolol for treatment of hemangioma of infancy and found that propranolol reduced VEGF levels but not ANG2 in saliva.16 This suggests that propranolol is not acting to decrease ANG2, and also, other angiogenic cytokines might be playing a role. This evidence concerns the gene VEGFA and hemangioma.